Market capitalization | $1.30b |
Enterprise Value | $1.62b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | negative |
EV/Sales (TTM) EV/Sales | 5.83 |
P/S ratio (TTM) P/S ratio | 4.65 |
P/B ratio (TTM) P/B ratio | 2.97 |
Revenue growth (TTM) Revenue growth | -48.78% |
Revenue (TTM) Revenue | $278.59m |
As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.
15 Analysts have issued a Maravai LifeSciences forecast:
15 Analysts have issued a Maravai LifeSciences forecast:
Jun '24 | |
Current assets | 685 685 |
Fixed assets | 762 762 |
Total Assets | 1,448 1,448 |
Jun '24 | |
Equity | 776 776 |
Debt capital | 671 671 |
Total Capital | 1,448 1,448 |
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Maravai Lifesciences Holdings, Inc. operates as an investment holding company. It develops biopharmaceuticals. The company is headquartered in San Diego, CA.
Head office | United States |
CEO | William Martin |
Employees | 650 |
Founded | 2014 |
Website | www.maravai.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.